- Home
- SOPH vs DSM Comparison
SOPH vs DSM Comparison
Compare SOPH & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOPH | DSM |
|---|---|---|
| Founded | 2011 | 1989 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.7M | 301.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SOPH | DSM |
|---|---|---|
| Price | $4.74 | $6.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 361.7K | 161.7K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $73,297,000.00 | N/A |
| Revenue This Year | $18.48 | N/A |
| Revenue Next Year | $15.82 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.66 | N/A |
| 52 Week Low | $2.58 | $4.69 |
| 52 Week High | $5.70 | $6.05 |
Technical Indicators
Market Signals| Indicator | SOPH | DSM |
|---|---|---|
| Relative Strength Index (RSI) | 42.03 | 59.59 |
| Support Level | $4.61 | $6.13 |
| Resistance Level | $5.06 | $6.23 |
| Average True Range (ATR) | 0.31 | 0.06 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 13.73 | 86.67 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.